March 2, 2018 09:45 AM EST
Financing

Amid a bois­ter­ous fundrais­ing week, Bio­Med­Part­ners airs $107M biotech fund

Brittany Meiling

As the VC dol­lars con­tin­ue to dom­i­nate bio­phar­ma head­lines this week, Swiss VC group Bio­Med­Part­ners AG has an­nounced its own wind­fall: it’s raised an ad­di­tion­al …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Up­dat­ed: No­vo’s 23% weight loss with Ca­griSe­ma falls short of high ex­pec­ta­tions, new tri­al planned

Califf, on his way out at FDA, pre­dicts agency tug-of-war be­tween Ra­maswamy and RFK Jr.

FDA ap­proves Hu­ma­cyte’s lab-grown blood ves­sels in mile­stone for re­gen­er­a­tive med­i­cine

Ex­clu­sive: Flori­da can­cer biotech rais­es $100M Se­ries A

Ac­cel­er­at­ed ap­proval brings Pfiz­er's BRAF in­hibitor to first-line pa­tients

A service from the Financial Times